The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of a Novel Benzodiazepine Series of Cbl-b Inhibitors for the Enhancement of Antitumor Immunity.EBI
Astrazeneca
A Survey of Recently Discovered Naturally Occurring Organohalogen Compounds.EBI
Dartmouth College
Oxetanes in Drug Discovery Campaigns.EBI
Imperial College London
Novel Lactams as CBL-B Inhibitors for Treating Cancer.EBI
Smith, Gambrell & Russell
A concise review on marine bromopyrrole alkaloids as anticancer agents.EBI
University of Kwazulu-Natal (Westville)
Novel Lactams as Cbl-b Inhibitors for Treating Cancer.EBI
Smith, Gambrell & Russell
Sinularamides A-G, Terpenoid-Derived Spermidine and Spermine Conjugates with Casitas B-Lineage Lymphoma Proto-Oncogene B (Cbl-b) Inhibitory Activities from a EBI
Yangzhou University
An affinity prediction approach for the ligand of E3 ligase Cbl-b and an insight into substrate binding pattern.EBI
China Pharmaceutical University
Lactams as CBL-B inhibitors selective over C-CBLBDB
Genentech
Cbl-b Inhibitors and Methods of Use ThereofBDB
Arcus Biosciences